Richard Steven Morris
CIK 1432303 · Chief Financial Officer · last filed 2024-06-18
Richard Steven Morris is a Chief Financial Officer who has filed 26 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for CARM, was dated Jun 18, 2024. Across all open-market trades the lifetime net is −$493.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VPHM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
EXTON, PA 19341
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. (CARM) Delisted | Chief Financial Officer | — | $0.00 | — | $0 | 3 | 2024-06-18 |
| PASG | Chief Financial Officer | 273 | $3.69 | $1.0K | $37.2K | 4 | 2021-05-21 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Chief Financial Officer | 0 | — | — | $0 | 4 | 2016-10-25 |
| VIROPHARMA INC (VPHM) Delisted | Chief Accounting Officer | 2,544 | — | — | -$530.3K | 14 | 2012-06-06 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-18 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-09 | — | Grant (A) | — | $0 | |
| 2021-05-21 | PASG | Buy (P) | +2,171 | $30.0K | EDGAR |
| 2021-02-18 | PASG | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | PASG | Buy (P) | +400 | $7.2K | EDGAR |
| 2020-03-02 | PASG | Grant (A) | — | $0 | EDGAR |
| 2016-10-25 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Disp (D) | −828 | -$17.4K | EDGAR |
| 2016-08-17 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | +828 | $5.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.